IPP Bureau
Zydus receives PAS approval for Mycophenolate Mofetil
By IPP Bureau - March 21, 2022
The drug is indicated for use in combination with other drugs
Mylab to open new facility in Vishakhapatnam
By IPP Bureau - March 21, 2022
Spread over 43,000 square feet, the facility will be set up to cater to the increasing demand for transformative molecular testing in India and across the world for early and accurate diagnosis
Hetero gets CDSCO approval to manufacture and sell Sputnik Light in India
By IPP Bureau - March 21, 2022
Sputnik Light is the first component of Sputnik V
Augnito.ai offers new features to woo doctors to its platform
By IPP Bureau - March 21, 2022
Augnito in association with Japanese company Fujifilm enables voice recognition within their radiology information system platform
Alembic Pharmaceuticals receives USFDA approval for Lacosamide tablets
By IPP Bureau - March 21, 2022
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
Wockhardt and Serum Life Sciences UK partner to manufacture multiple vaccines in UK
By IPP Bureau - March 21, 2022
The facility will produce 150 million vaccine doses per year
ABclonal Technology joins YCharOS advisory committee to tackle reproducibility crisis in biomedical research
By IPP Bureau - March 21, 2022
Inconsistent antibody performance is a significant challenge for researchers and sits at the heart of the reproducibility crisis observed in biomedical research
RNAGene and PharmAbcine to develop novel mRNA therapeutics
By IPP Bureau - March 21, 2022
mRNA-based therapies involve the administration of mRNA in patients so that patients' own cells can produce the encoded therapeutic antibody
Lonza signs manufacturing agreement with Oasmia Pharmaceutical
By IPP Bureau - March 21, 2022
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
Govt to deploy Truenat platform for TB screening across India
By IPP Bureau - March 19, 2022
It is a point-of-care portable, battery-operated, IoT-enabled platform with a sample to result in less than 1 hour
Jubilant Pharmova arm receives ANDA approval for psychoneurosis drug
By IPP Bureau - March 19, 2022
The generic version of Sinequan, which is used for the treatment of anxiety, depression, and other target symptoms of psychoneurosis
Akston Biosciences and Biolexis partner to develop second-gen COVID-19 vaccine
By IPP Bureau - March 19, 2022
Biolexis will also leverage the capabilities of Strides Group for launching this vaccine across regions where the group has a deep market presence and established relationships
Manipal Hospitals deploys wearable technology to monitor post-surgery care
By IPP Bureau - March 19, 2022
Manipal Hospitals partners with ConnectedLife, leveraging Fitbit wearable technology, for Continuity of Care Post-High-Risk Surgeries built with Google Cloud
USFDA approves Opdualag to treat metastatic melanoma
By IPP Bureau - March 19, 2022
Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the PD-1 inhibitor nivolumab and novel LAG-3-blocking antibody relatlimab
Tata Elxsi has unveiled TEngage, a digital health platform
By IPP Bureau - March 19, 2022
In contrast to the digital health solutions in the market, TEngage is cloud-based, fully customizable and allows hospitals to implement modules with just the required features, keeping the deployment and operational cost in check
